Achieve Life Sciences (ACHV) Shares Outstanding (Diluted Average) (2010 - 2026)

Achieve Life Sciences has disclosed Shares Outstanding (Diluted Average) across 10 years of filings, most recently posting $53.4 million for Q1 2026.

• Quarterly Shares Outstanding (Diluted Average) rose 53.9% year-over-year to $53.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.4 million (up 53.9% YoY) and the FY2025 annual result came in at $43.6 million, up 35.93% from the prior year.
• Shares Outstanding (Diluted Average) grew to $53.4 million in Q1 2026, from $43.6 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $53.4 million in Q1 2026 and troughed at $9.5 million in Q1 2022.
• A 5-year average of $26.9 million and a median of $25.0 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Diluted Average) soared 120.05% — and 2025, when it advanced 1.07%.
• Tracing ACHV's Shares Outstanding (Diluted Average) over 5 years: stood at $10.6 million in 2022, then soared by 87.18% to $19.8 million in 2023, then soared by 61.75% to $32.1 million in 2024, then soared by 35.93% to $43.6 million in 2025, then climbed by 22.45% to $53.4 million in 2026.
• Business Quant data shows ACHV's Shares Outstanding (Diluted Average) at $53.4 million in Q1 2026, $43.6 million in Q4 2025, and $51.0 million in Q3 2025.